Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis.

PloS one·2013
Same author

Phylogenomic analyses of nuclear genes reveal the evolutionary relationships within the BEP clade and the evidence of positive selection in Poaceae.

PloS one·2013
Same author

A general and robust strategy for the synthesis of nearly monodisperse colloidal nanocrystals.

Nature nanotechnology·2013
Same author

AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.

Proceedings of the National Academy of Sciences of the United States of America·2013
Same author

Identification and functional characteristics of chlorpyrifos-degrading and plant growth promoting bacterium Acinetobacter calcoaceticus.

Journal of basic microbiology·2013
Same author

[Study on the chemical constituents of Buddleja davidii].

Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials·2013

Related Experiment Video

Updated: Jun 11, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

IPM-DTI: An Interaction-Pattern-Driven Multimodal Framework for Drug-Target Interaction Prediction via Knowledge

Yao Liu1, Yifei Zhou2, Xin Wang3

  • 1College of Information and Electrical Engineering, China Agricultural University, Beijing 100083, China.

Journal of Chemical Information and Modeling
|June 9, 2026
PubMed
Summary

Predicting drug-target interactions (DTIs) is crucial for drug discovery. Our new framework integrates diverse data and knowledge graphs to uncover complex interaction patterns, improving prediction accuracy over existing methods.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 11, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

  • Computational drug discovery
  • Bioinformatics
  • Artificial Intelligence in Medicine

Background:

  • Accurate drug-target interaction (DTI) prediction is vital for computational drug discovery.
  • Existing multimodal methods often overlook complex, high-order interaction patterns.
  • Knowledge graphs (KGs) can reveal indirect associations but face computational challenges in large search spaces.

Purpose of the Study:

  • To develop a novel multimodal DTI prediction framework, IPM-DTI, that leverages learned interaction patterns.
  • To integrate heterogeneous data including protein sequences, molecular graphs, and KG structures for enhanced DTI prediction.
  • To address the computational challenges of KG traversal for identifying latent drug-target associations.

Main Methods:

  • Constructed an explicit DTI knowledge graph (KG) from DTI databases.
  • Employed multimodal encoders to map drugs and targets into a unified latent space, extracting cross-modal features.
  • Decomposed the global DTI KG into semantic subspaces and utilized an RL-based reasoning module for navigating these subspaces.
  • Integrated structure- and RL-derived results via a multisource fusion module for comprehensive DTI prediction.

Main Results:

  • The proposed IPM-DTI framework demonstrated superior performance compared to single-modal and single-embedding baseline methods.
  • The integration of heterogeneous data and learned interaction patterns significantly improved DTI prediction accuracy.
  • The RL-based reasoning module effectively navigated KG subspaces to identify latent drug-target associations.

Conclusions:

  • The IPM-DTI framework effectively captures complex, high-order interaction patterns for accurate DTI prediction.
  • Integrating multimodal data with KG structures and RL-guided reasoning enhances computational drug discovery.
  • This approach offers a promising direction for improving the efficiency and accuracy of identifying potential drug candidates.